Skip to content

SYNABS

Active
Public limited companyfounded 201510 yrs activeRue Auguste Piccard 48, 6041 Charleroi, BelgiumKBO/BCE: BE 0637.716.206

SYNABS has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €665k and a net result of €459k. Equity is growing by ~14.6% per year across the filed fiscal years. Its solvency ranks better than 36% of 308 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2024
86 / 100
Excellent▼ -14 vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency77▲+9
Growth78=
Stability100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55k at 30 days acceptable
Liquidity ample (current ratio 1.76 against 1.6 in 2023), but 60.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 20
Relative position
BE, all sectors
reference
Sector 20
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
39.2%
Return on assets
27%
Age of the figures
20 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 04-04-2025, 118 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
not confirmed
2024
118 d early
2023
75 d early
2022
26 d early
2021
13 d early
2020
16 d early
2019
30 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, full schema

Turnover
€1.26M
EBIT margin
5.0%
Net result
€459k▼ 9.7%
2023 · €508k
2018: €31k 2019: €109k 2020: €-65k 2021: €183k 2022: €56k 2023: €508k
2018 → 2024
Working capital
€669k▲ 37.0%
2023 · €488k
2018: €111k 2019: €165k 2020: €154k 2021: €319k 2022: €341k 2023: €488k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Turnover€1.26M
Equity€332k-€509k▲ 53.4%€501k▼ 1.5%€509k▲ 1.6%€665k▲ 30.5%
Operating result€-261k-€-57k▲ 78.2%€-314k▼ 450%€63k€216k▲ 243%
Net result€-65k-€183k€56k▼ 69.6%€508k▲ 815%€459k▼ 9.7%
Result per fiscal year
Operating resultNet result
€-500k€-250k€0€250k€500kOperating result 2020: €-261k€-261kNet result 2020: €-65k€-65kOperating result 2021: €-57k€-57kNet result 2021: €183k€183kOperating result 2022: €-314k€-314kNet result 2022: €56k€56kOperating result 2023: €63k€63kNet result 2023: €508k€508kOperating result 2024: €216k€216kNet result 2024: €459k€459k20202021202220232024
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 243% above 2023 and is the highest year so far.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.70M
Fixed assets €146k▼ 9.4%
Current assets €1.55M▲ 18.7%
Equity and liabilities €1.70M
Equity €665k▲ 30.5%
Debt €1.03M▲ 7.7%
The debt ratio falls from 65.3% to 60.8%: equity grows faster than debt.
Key figures and ratios
2024 value · change against 2023
EBITDA
€897k
2023 · €753k
Cash flow
€1.14M
2023 · €1.20M
Solvency
39.2%
2023 · 34.7%
Current ratio
1.76
2023 · 1.60
Quick ratio
1.52
2023 · 1.36
Debt / equity
1.55
2023 · 1.88
ROE
69.0%
2023 · 99.9%
ROA
27.0%
2023 · 34.7%
Interest coverage
62.01
2023 · 214.40
Debt
€1.03M
2023 · €958k
Debt ≤ 1 year
€882k
2023 · €818k
Debt > 1 year
€149k
2023 · €139k
Income taxes
€61k
2023 · €18k
Staff costs
€421k
2023 · €437k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€1.47M€1.70M
Fixed assets21/28€161k€146k
Intangible fixed assets21€38k€25k
Tangible fixed assets22/27€113k€121k
Plant, machinery and equipment23€111k€105k
Furniture and vehicles24€2k€11k
Other tangible fixed assets26€261€5k
Financial fixed assets28€10k€0
Current assets29/58€1.31M€1.55M
Stocks and contracts in progress3€190k€214k
Stocks30/36€190k€214k
Amounts receivable within one year40/41€678k€582k
Trade receivables40€187k€222k
Other amounts receivable41€490k€360k
Cash at bank and in hand54/58€395k€700k
Deferred charges and accrued income490/1€44k€55k
Equity and liabilities
Total equity and liabilities10/49€1.47M€1.70M
Equity10/15€509k€665k
Contributions10/11€360k€360k=
Capital10€360k€360k=
Issued capital100€360k€360k=
Reserves13€27k€36k
Non-distributable reserves130/1€27k€36k
Legal reserve130€27k€36k
Profit (loss) carried forward14€117k€266k
Investment grants15€6k€3k
Amounts payable17/49€958k€1.03M
Amounts payable after more than one year17€139k€149k
Financial debts170/4€139k€149k
Amounts payable within one year42/48€818k€882k
Current portion of amounts payable after more than one year42€31k€181k
Trade debts44€216k€309k
Suppliers440/4€216k€309k
Advances received on contracts in progress46€0-
Taxes, remuneration and social security45€72k€92k
Taxes450/3€18k€25k
Remuneration and social security454/9€54k€67k
Other amounts payable47/48€500k€300k
Accrued charges and deferred income492/3€492€606
Income statement Code20232024
Turnover70€1.26M-
Goods, raw materials, services and sundry goods60/61€730k-
Remuneration, social security and pensions62€437k€421k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€690k€680k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€116k
Other operating charges640/8€1k€5k
Non-recurring operating charges66A€35k€0
Gross operating margin9900€1.23M€1.44M
Operating profit (loss)9901€63k€216k
Financial income75/76B€467k€318k
Recurring financial income75€467k€318k
Financial charges65/66B€4k€14k
Recurring financial charges65€4k€14k
Profit (loss) for the period before taxes9903€527k€520k
Income taxes67/77€18k€61k
Profit (loss) for the period9904€508k€459k
Profit (loss) for the period to be appropriated9905€508k€459k
Appropriation of the result
Profit (loss) to be appropriated9906€642k€575k
Profit (loss) brought forward from the previous period14P€134k€117k
Transfer to equity691/2€25k€9k
To the legal reserve6920€25k€9k
Profit to be distributed694/7€500k€300k
Return on contributions (dividend)694€500k€0
Directors or managers695-€300k
Social balance
Average headcount (FTE)90876.66.1

The notes to these accounts (21 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
04-04
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
17-05
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Highest result since 2018net €508k ▲815%
Net result €508k, the highest in the series.
05-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
18-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial Back to profitnet €183k
Net result €183k after one loss-making year.
31-12
Financial Equity above €500kEq €509k ▲53.4%
Equity rises from €332k to €509k.
15-07
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial Weakest financial yearnet €-65k ▼160%
Net result drops to €-65k, the lowest in the series; recovery starts the following year.
01-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
21-05
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
08-06
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
29-05
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 directors, no change since 2023
ISY INVEST
Director · since 30-11-2023 · Legal entity · perm. rep.: ISOARD Julien
Current
30-11-2023 ISY INVEST: Appointed as Director
30-11-2023 MATHIEU Christophe: Resigned as Director
Location & real-estate footprint
Registered office, Charleroi · 1 establishment unit since 2015
establishment approximate The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue Auguste Piccard 486041 Charleroi
Ground area
8,679 m²
Building footprint
791 m²
Volume, LiDAR
12,567 m³
Parcel 52028B0323/00M003, Wallonia · tallest building 18.8 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
SYNABS
Rue Auguste Piccard 48, 6041 CharleroiManufacture of chemicals and chemical products
since 20152.245.293.543
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
52028B0323/00M003 Wallonia 8,679 m² 1 · 791 m² 18.8 m · 5 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

European Union, budget

2022 · 1 entry · 602,290 EUR in total
Year Entries awarded
2022 1 602,290 EUR
Projects
101099063 - APTADEGRAD - A NOVEL, FIRST-IN-ITS-KIND, APTAMER-BASED LYTACS TO ADDRESS THE UNMET CLINICAL NEED OF DIABETIC WOUNDS.
1.0.11 - Horizon Europe · 01-12-2022 to 30-11-2027 · 602,290 EUR

European research

1 project · 602,289 EUR EU contribution
Programmes
HORIZON
1 entry · 602,289 EUR
Projects
A novel, first-in-its-kind, aptamer-based LYTACs to address the unmet clinical need of diabetic wounds.
HORIZON · participant · 01-12-2022 to 30-11-2027 · 602,289 EUR · APTADEGRAD

Similar companies · same sector, comparable size

Of 229 companies in sector 20590 we hold annual accounts for 168. 89 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded14-09-2015
Fiscal year end31-12
Activities, NACEBEL
20590Manufacture of chemicals and chemical products
72101Research and development on biotechnology
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers

Data from official sources, last processed on 11-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

1 entry
Phone:0470/895618
Establishment Charleroi 2.245.293.543